SCHEMBL2200156

SCHEMBL2200156

ClCOc1ccccc1C1CNCC[N]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 10/20 0.37
ADRA1A P35348 3/20 0.37
ADRA1D P25100 2/20 0.37
ADRA1B P35368 2/20 0.37
NISCH Q9Y2I1 2/20 0.37
ADRA2C P18825 2/20 0.37
CYP1A2 P05177 1/20 0.37
ADRA2A P08913 1/20 0.37
CYP2D6 P10635 1/20 0.37
THRB P10828 1/20 0.37
TSHR P16473 1/20 0.37
ADRA2B P18089 1/20 0.37
CYP2C19 P33261 1/20 0.37
THPO P40225 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SLC6A2 P23975 9/20 0.37
SLC6A4 P31645 9/20 0.37
SLC6A3 Q01959 7/20 0.37
LMNA P02545 1/20 0.36
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2204690 0.86 SLC6A2 (0.46) HTR1AADRA1AADRA1DADRA1BNISCH
SCHEMBL4720203 0.83 HTR2B (0.45) HTR1AADRA1AADRA1DADRA1BNISCH
SCHEMBL446838 0.83 SLC6A4 (0.57) HTR1AADRA1AADRA1DADRA1BNISCH
SCHEMBL4723022 0.82 TP53 (0.41) HTR1AADRA1AADRA1DADRA1BNISCH
SCHEMBL1254378 0.81 HTR2C (0.51) HTR1AADRA1AADRA1DADRA2CCYP2C19
SCHEMBL1254662 0.75 TAAR1 (0.41) HTR1ATSHRHSD17B10SLC6A2SLC6A4
SCHEMBL9158101 0.72 HTR2C (0.49) HTR1AADRA2CSLC6A2SLC6A4SLC6A3
SCHEMBL2204913 0.72 HTR2C (0.47) HTR1ANISCHSLC6A2SLC6A4HTR2A
SCHEMBL3549378 0.72 KDM1A (0.42) HTR1ANISCHSLC6A2SLC6A4SLC6A3
SCHEMBL10682669 0.72 CHRNB2 (0.37) ADRA2CCYP1A2CYP2D6TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 HTR1A 1960/4885ADRA1A 4131/4885ADRA1D 4086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.